# (Val)Ganciclovir TDM in Transplant Recipients

> **NCT03698435** · — · UNKNOWN · sponsor: **University Medical Center Groningen** · enrollment: 100 (estimated)

## Conditions studied

- Cytomegalovirus Infections

## Interventions

- **DRUG:** Ganciclovir
- **DRUG:** Valganciclovir

## Key facts

- **NCT ID:** NCT03698435
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-05-25
- **Primary completion:** 2019-11-30
- **Final completion:** 2019-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2019-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03698435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03698435, "(Val)Ganciclovir TDM in Transplant Recipients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03698435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*